28.07
price down icon2.37%   -0.68
pre-market  Vorhandelsmarkt:  27.69   -0.38   -1.35%
loading

Avalyn Pharma Inc Aktie (AVLN) Neueste Nachrichten

pulisher
Jun 11, 2026

IPO Tracker 2026: Kardigan stitches up $369M IPO plan - BioSpace

Jun 11, 2026
pulisher
Jun 08, 2026

Avalyn Pharma (AVLN) Earnings Date and Reports 2026 - MarketBeat

Jun 08, 2026
pulisher
Jun 06, 2026

Avalyn Pharma Inc.common stock (AVLN) Stock Price, News, Quote & History - FinancialContent

Jun 06, 2026
pulisher
Jun 05, 2026

Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead - inkl

Jun 05, 2026
pulisher
Jun 05, 2026

Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53 - 富途牛牛

Jun 05, 2026
pulisher
Jun 04, 2026

Avalyn Pharma Inc. 2026 Q1 Financial Report and Material Risks Overview - Minichart

Jun 04, 2026
pulisher
Jun 04, 2026

Avalyn Pharma 1Q Loss $26.9M >AVLN - Moomoo

Jun 04, 2026
pulisher
Jun 04, 2026

AVLN SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus

Jun 04, 2026
pulisher
Jun 03, 2026

Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026 - MarketBeat

Jun 03, 2026
pulisher
Jun 03, 2026

Avalyn Pharma Inc. 1Q 2026: Net income $(26.9M), EPS $(21.83) — 10-Q Summary - TradingView

Jun 03, 2026
pulisher
Jun 03, 2026

Avalyn: Q1 Earnings Snapshot - marketscreener.com

Jun 03, 2026
pulisher
Jun 03, 2026

AVLN: Q1 2026 net loss widened to $26.9M; IPO proceeds extend cash runway into 2029, but more funding needed - TradingView

Jun 03, 2026
pulisher
Jun 03, 2026

Avalyn Pharma (Nasdaq: AVLN) widens Q1 loss but extends cash runway into 2029 - Stock Titan

Jun 03, 2026
pulisher
Jun 03, 2026

Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights - The Manila Times

Jun 03, 2026
pulisher
Jun 02, 2026

Avalyn Pharma (AVLN) Stock Chart and Price History 2026 - MarketBeat

Jun 02, 2026
pulisher
Jun 01, 2026

Avalyn Pharma (AVLN) Stock Analysis Report | Financials & Insights - Benzinga

Jun 01, 2026
pulisher
Jun 01, 2026

Assessing Avalyn Pharma (AVLN) Valuation As Investors React To Recent Share Price Moves - Yahoo Finance

Jun 01, 2026
pulisher
May 30, 2026

Top Avalyn Pharma (AVLN) Competitors 2026 - MarketBeat

May 30, 2026
pulisher
May 29, 2026

Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

May 29, 2026
pulisher
May 27, 2026

Avalyn Pharma Inc.: Target Price Consensus and Analysts Recommendations | AVLN | US05348Y1055 - marketscreener.com

May 27, 2026
pulisher
May 27, 2026

Avalyn to Participate in the Jefferies Global Healthcare Conference - GlobeNewswire

May 27, 2026
pulisher
May 26, 2026

AVLN Initiated Coverage by Morgan Stanley -- Price Target Set at $53 - GuruFocus

May 26, 2026
pulisher
May 26, 2026

AVLN Initiates Coverage by Guggenheim -- Price Target Announced at $80 - GuruFocus

May 26, 2026
pulisher
May 26, 2026

This Lear Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday - Benzinga

May 26, 2026
pulisher
May 26, 2026

Jefferies Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $52 - 富途牛牛

May 26, 2026
pulisher
May 26, 2026

This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

May 26, 2026
pulisher
May 26, 2026

Guggenheim Initiates Avalyn Pharma at Buy With $80 Price Target - Moomoo

May 26, 2026
pulisher
May 26, 2026

Morgan Stanley Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $53 - Moomoo

May 26, 2026
pulisher
May 26, 2026

Jefferies Initiates Avalyn Pharma at Buy With $52 Price Target - Moomoo

May 26, 2026
pulisher
May 26, 2026

Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating By Investing.com - Investing.com South Africa

May 26, 2026
pulisher
May 26, 2026

Morgan Stanley initiates Avalyn Pharma stock coverage with overweight rating - Investing.com Australia

May 26, 2026
pulisher
May 25, 2026

Avalyn Pharma (AVLN) Stock Forecast and Price Target 2026 - MarketBeat

May 25, 2026
pulisher
May 25, 2026

Jefferies initiates Avalyn Pharma stock with buy on lung disease data - Investing.com India

May 25, 2026
pulisher
May 25, 2026

Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs By Investing.com - Investing.com Australia

May 25, 2026
pulisher
May 25, 2026

Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs - Investing.com UK

May 25, 2026
pulisher
May 25, 2026

Jefferies Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $52 - Moomoo

May 25, 2026
pulisher
May 22, 2026

AVLN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

May 22, 2026
pulisher
May 22, 2026

AVLN Technical Analysis | Trend, Signals & Chart Patterns | AVALYN PHARMA INC (NASDAQ:AVLN) - ChartMill

May 22, 2026
pulisher
May 21, 2026

Avalyn Pharma to present 4-year AP01 data at EULAR conference By Investing.com - Investing.com South Africa

May 21, 2026
$30.41
price up icon 1.27%
$55.40
price up icon 6.27%
$89.50
price down icon 1.43%
$54.21
price down icon 0.11%
ONC ONC
$263.92
price down icon 1.60%
$156.58
price down icon 2.17%
Kapitalisierung:     |  Volumen (24h):